Q301--Pharmacy Sterile Compounding Services
ID: 36C24625Q0158Type: Presolicitation
Overview

Buyer

VETERANS AFFAIRS, DEPARTMENT OFVETERANS AFFAIRS, DEPARTMENT OF246-NETWORK CONTRACTING OFFICE 6 (36C246)HAMPTON, VA, 23667, USA

NAICS

Testing Laboratories and Services (541380)

PSC

MEDICAL- LABORATORY TESTING (Q301)
Timeline
    Description

    The Department of Veterans Affairs is seeking an accredited clinical laboratory to provide pharmacy sterile compounding services for the Durham VA Medical Center and the Greenville Health Care Center. The procurement aims to ensure compliance with federal standards while supporting essential healthcare services for veterans. The solicitation, identified as RFQ 36C24625Q0158, is anticipated to be issued around November 5, 2024, with a five-day response window for interested contractors. Bidders must be registered in the System for Award Management (SAM) and, if applicable, the VetBiz database, with no physical copies of the solicitation provided. For further inquiries, contractors can contact Contract Specialist Cherisse Hall at Cherisse.Hall@va.gov or by phone at 757-726-6096.

    Point(s) of Contact
    Cherisse HallContract Specialist
    (757) 726-6096
    Cherisse.Hall@va.gov
    Files
    Title
    Posted
    The Veterans Health Administration seeks to contract pharmacy sterile compounding services for its Durham VA Medical Center and Greenville HCC. The solicitation number for this Request for Quote (RFQ) is 36C24625Q0158, anticipated to be issued around November 5, 2024, with a response window of five days following issuance. The contract will be a firm-fixed price agreement, with bidders required to maintain active registration in the System for Award Management (SAM) and, if applicable, the VetBiz database for Service-Disabled Veteran-Owned or Veteran-Owned Small Businesses. The relevant Product Service Code is Q301, and the NAICS code is 541380. Interested contractors must download the solicitation from the SAM website, as no physical copies will be provided. This presolicitation notice indicates the VA's plan to procure vital pharmacy compounding services, ensuring compliance with federal procurement standards and support for veterans' healthcare services.
    Lifecycle
    Title
    Type
    Presolicitation
    Similar Opportunities
    6505--770-25-1-801-0021 -National CMOP DORZOLAMIDE/TIMOLOL -VA-25-00011267)
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking to procure DORZOLAMIDE/TIMOLOL ophthalmic solution for its Centralized Mail Order Pharmacy (CMOP) facilities. This procurement involves acquiring quantities ranging from 2,880 to 9,600 units of 10ML packaging, with a focus on ensuring compliance with the Drug Supply Chain Security Act and other regulatory standards. The pharmaceutical products are critical for providing necessary medical care to veterans, reflecting the VA's commitment to delivering high-quality healthcare solutions. Interested vendors must submit their quotations by November 12, 2024, following the release of the solicitation on November 4, 2024, and can direct inquiries to Contract Specialist Kelley Cunningham at kelley.cunningham@va.gov.
    6505-- Pegfilgrastim
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is preparing to issue a Request for Proposal (RFP) numbered 36E79725R0001 for the procurement of Pegfilgrastim, aimed at ensuring a continuous supply for various entities including VA facilities, Consolidated Mail Order Pharmacies, Bureau of Prisons, Indian Health Service, and Federal Health Care Centers. The contract will be awarded to a responsible offeror capable of providing Pegfilgrastim with a unique National Drug Code (NDC) and adhering to strict labeling guidelines, prohibiting the affixing of new labels over existing ones. The estimated annual requirement is for 8,458 syringes across multiple variants, with the RFP expected to be released electronically around November 5, 2024, and responses due by November 19, 2024. Interested parties should monitor sam.gov for updates and direct inquiries to Contract Specialist Matthew Poulin at Matthew.Poulin@va.gov or by phone at 708-786-5186.
    Simplifi 797 and Simplifi+Medstorage or Equal
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs, specifically the Network Contracting Office 16, is seeking quotes for the procurement of Simplifi 797 and Simplifi+ MedStorage or equivalent software to enhance compliance with U.S. Pharmacopeial Convention (USP) standards for sterile compounding. The required software must provide a web-based quality management system that automates compliance with USP 795, 797, and 800 standards, while also facilitating necessary training and documentation for pharmacy staff to adhere to storage protocols and quality assurance practices in medication management. This acquisition is critical for maintaining high standards in medication safety and quality control, with quotes due by November 5, 2024, and the contract spanning a base period of one year with four additional option periods. Interested vendors should submit detailed quotes electronically, including past performance references and pricing, to Caleb Parker at caleb.parker@va.gov or by phone at (713) 791-1414 ext. 149866.
    6640--VA Central California Health Care System Chemistry & Immunoassay CPRR Equipment and Tests
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is seeking qualified contractors to provide clinical laboratory analyzer equipment for Chemistry and Immunoassay testing on a Cost Per Reportable Result (CPRR) basis for the VA Central California Health Care System. This procurement involves a five-year Indefinite Delivery, Indefinite Quantity (IDIQ) contract, which will span from April 2025 to September 2029, and includes specific ordering periods for various laboratory tests and equipment. The initiative is crucial for enhancing diagnostic capabilities and ensuring high-quality healthcare services for veterans, with a focus on automation, reliability, and compliance with federal regulations. Interested parties can contact Contract Specialist Tawnya S Krommenhoek at tawnya.krommenhoek@va.gov or David J. Alvarez at david.alvarez4@va.gov for further details regarding the solicitation, identified as 36C26125Q0065.
    Q517--Staffing Service MbM
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking proposals for staffing services under the Meds by Mail (MbM) program, specifically targeting Service-Disabled Veteran-Owned Small Businesses (SDVOSB). The procurement aims to provide licensed pharmacists and certified pharmacy technicians to support prescription processing across three facilities located in Cheyenne, WY; Dublin, GA; and Murfreesboro, TN. This initiative is crucial for enhancing healthcare services for veterans, ensuring efficient medication management and compliance with established protocols. Interested vendors must submit their proposals by the newly established deadline of August 6, 2024, with a total contract value estimated at $100 million over five years, including a minimum guarantee of $2 million. For further inquiries, potential bidders can contact Nicholas L. Schulte at nicholas.schulte1@va.gov or Christy Pendlay at Christy.Pendlay@va.gov.
    6505--770_Pharmaceuticals_VA CMOP National Office_36C77025Q0052 770-25-1-801-0071 -National CMOP FERROUS SULFATE
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is seeking bids for an emergency procurement of Ferrous Sulfate 324MG EC Tablets, specifically packaged in bottles of 100, to be delivered to various Consolidated Mail Outpatient Pharmacy (CMOP) facilities across the United States. The procurement requires a total of seven different quantities ranging from 1,200 to 9,600 units, with a delivery timeframe of 10 days after receipt of order (ARO). This initiative is crucial for maintaining a reliable pharmaceutical supply chain to support the healthcare needs of veterans. Interested vendors must submit their proposals by November 6, 2024, at 9:00 AM CST, including a signed SF1449 cover page, a price schedule in Excel format, a state wholesale distributor license, and a completed Trade Agreements Certificate, with the estimated award date set for November 12, 2024. For further inquiries, vendors can contact Contract Specialist Michael W. McAlhaney at Michael.McAlhaney@va.gov or (913) 684-0134.
    6505--S0578 SEVELAMER CARBONATE 800MG TAB (VA-25-00008856)
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is seeking qualified vendors to procure Sevelamer Carbonate 800mg tablets for delivery to multiple Consolidated Mail Outpatient Pharmacy (CMOP) facilities. The procurement aims to ensure an adequate supply of this essential pharmaceutical, which plays a critical role in the healthcare of veterans, with a total requirement of 8,480 tablets across various locations including Leavenworth, Chelmsford, Tucson, Dallas, Murfreesboro, Great Lakes, and Charleston. Interested parties must submit their quotations by October 31, 2024, including a signed SF1449 cover page, a completed pricing schedule, a valid State Wholesale Distributor License, and a Trade Agreements Act certificate, with all submissions directed to Contract Specialist Kelley Cunningham at kelley.cunningham@va.gov.
    6505--Betamethasone RFP
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is soliciting proposals for the supply of Betamethasone Dipropionate Cream, a pharmaceutical product essential for the healthcare of veterans. Offerors are required to submit competitive pricing for a base year and four option years, including a mandatory 0.5% Cost Recovery Fee, while ensuring compliance with the Drug Supply Chain Security Act and Good Manufacturing Practices. This contract is vital for maintaining a consistent supply of medications through the VA and Department of Defense's Prime Vendor Programs, emphasizing the government's commitment to providing quality healthcare to service members. Interested vendors should contact Contract Specialist Amber Zavala at amber.zavala@va.gov for further details regarding the solicitation.
    6505--Radiopharmaceuticals Indefinite Quantity VA San Diego Base Year Only
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking quotes for an indefinite quantity contract for radiopharmaceuticals to support the VA San Diego Healthcare System. The contractor will be responsible for providing a range of nuclear medicine supplies and services, including I-123 and I-131 capsules, as well as technetium-based radiopharmaceuticals, while adhering to strict regulations against gray market goods. This procurement is crucial for ensuring the delivery of quality healthcare to veterans, with the contract set to commence on November 12, 2024, and an estimated minimum value of $100,000 and a maximum of $350,000. Interested vendors must be registered in SAM.gov and submit their quotes electronically, with inquiries directed to Contracting Officer Adrienne Brown at adrienne.brown4@va.gov or 951-601-4536.
    Q517--Omnicell New Preventative Maintenance Service Package
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) Network Contracting Office 19 intends to award a sole source Fixed Price Indefinite Delivery/Indefinite Quantity (ID/IQ) contract to Omnicell, INC. for the provision of preventative maintenance and support for the Omnicell Medication Supply Station and System. This contract will include enhancements such as the addition of new software and capabilities, ensuring the operational efficiency of the medication dispensing systems critical to healthcare services. Interested firms may submit written notifications demonstrating their ability to meet the requirements by November 14, 2024, at 10:00 AM Mountain Standard Time, with all responses directed to Contract Specialist David Glanton at david.glanton@va.gov. Contractors must be registered in the System for Award Management (SAM) to be eligible for consideration, and the estimated period of performance for this contract is from February 1, 2025, to January 31, 2028.